Jilin Aodong extends employee stock ownership plan for 12 months

Jilin Aodong Pharmaceutical Group Co., Ltd. approved the extension of its first employee stock ownership plan at the 22nd meeting of its eleventh board of directors on December 5, 2025. The plan, initially approved on July 15, 2016, will now expire on December 8, 2026, an extension of 12 months. This decision followed a meeting of the employee stock ownership plan management committee on December 1, 2025, where all participants voted in favor.

The extension affects 25,502,666 shares held by the plan, representing approximately 2.13% of the company's total share capital. The initial plan involved buying 19,809,743 shares through the company's buyback program by December 30, 2016. Previous extensions were approved on June 14, 2019 (18 months), October 30, 2020 (36 months), and November 7, 2023 (24 months).

Six directors, including chairman Li Xiulin, who participate in the employee stock ownership plan, recused themselves from the vote. The resolution passed with three votes in favor, none against, and no abstentions.